Creative Computer Applications, Inc. (AMEX:CAP) Appoints William Blair as Vice President of Sales, and Douglas A. Collie as Imaging Product Manager.

CALABASAS, Calif. -- Creative Computer Applications, Inc. or CCA (AMEX:CAP), a provider of Clinical Information Systems (CIS) for hospital and clinic-based laboratories, pharmacies, and imaging departments, today that it recently announced the appointment of William W. "Bill" Blair as Vice President of Sales, and Douglas A. Collie as Imaging Product Manager.

Mr. Blair will be responsible for the management of sales and business development for the Information Solutions provided by CCA, including the complete suite of products - CyberLAB(R), CyberMED(R), and CyberRAD(R). He brings to CCA 32 years of experience in the healthcare technology industry, with previous positions held at both Sunquest Information Systems (now Misys Healthcare Systems) and Sysmex America. He has demonstrated leadership, problem solving, and planning skills that have maximized sales and created market-driven products.

Steven M. Besbeck stated, "We are very excited to add Bill to the team. He has a proven track record of increasing sales in the clinical information system marketplace, and I am certain he will have an overall positive effect on our sales process and will become a key member of our management team."

"I am very happy to join CCA with its long tradition of innovative and high quality products. Our focus always has been, and will continue to be, to provide the best solutions for the ever-changing clinical marketplace," Mr. Blair commented.

Douglas Collie is a healthcare industry veteran with18 years of experience in Healthcare IT on both the vendor and payer side of the business. For the last 9 years, he has specialized in Radiology subspecialty of healthcare in the areas of PACS, RIS, and digital equipment. He will be responsible for the product management of the imaging product line, including the CyberRAD RIS, integrated RIS/PACS solution, and StorCOMM's AccessNET PACS following the completion of the merger between the two companies.

"I am glad to have such a strong imaging management knowledge source with Doug as our Imaging Product Manager. He will be an asset to our product management and marketing team, and will provide benefits to current and new clients alike," stated Michelle Del Guercio, CCA Director of Marketing and Product Management.

Mr. Collie stated, "I am happy utilize my experience in the imaging industry to help in providing solutions that ultimately provide for better patient care. Many exciting new projects are already underway and I look forward to the positive response we will get from prospects and existing clients."

CCA is a healthcare information technology and service provider that provides software and browser-based solutions, specializing in Clinical Information Systems (CIS) for hospital and clinic-based laboratories, pharmacies, and imaging departments. Its primary products, CyberLAB(R), CyberMED(R) and CyberRAD(R) are highly functional, scalable, and can be deployed in a variety of healthcare settings. CCA's systems are deployed in more than 500 sites. For more information about CCA, its products and services, visit http://www.ccainc.com/. As previously announced, CCA is merging with StorCOMM a provider of picture archive communication systems (PACS). The merger is expected to be completed this summer.

This news release contains forward-looking statements made in reliance upon the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are not guarantees of future performance and are inherently subject to uncertainties and other factors which could cause actual results to differ materially from the forward-looking statement. Such statements are based upon, among other things, assumptions made by, and information currently available to, management, including management's own knowledge and assessment of the Company's industry and competition. The Company refers interested persons to its most recent Annual Report on Form 10-KSB and its other SEC filings for a description of additional uncertainties and factors, which may affect forward-looking statements. The Company assumes no duty to update its forward-looking statements.